You’ll hear from Mikesh Udani, CEO of Albus Health, who offer contactless remote monitoring solutions for clinical trials to monitor patients during sleep without burdening them. Albus Health graduated from our Market Access Accelerator programme in 2020 and since then have acquired regulatory approval for the US and Europe, and has inbound paid pilots from multiple clients, including AstraZeneca, and others in the pipeline. The platform is currently being extended to preventative healthcare that include two of the UK’s largest paediatric hospitals in a project fully funded by the UK’s Department of Health.
Also joining us is Dr. Andreas Halner, President and Chief Operating Officer of OXCan, which has an award-winning company supported by the Oxford Foundry, Cancer Research UK and the Francis Cricket Institute. Following graduation from our MAA in 2023, they closed Series A funding round after securing USD$11 million. This investment brings OXCan’s total funding to date to USD$16.7m, positioning the company to develop and globally commercialise its new generation of minimally invasive liquid biopsy tests for early cancer detection.
Both will share the highs, the lows and everything in between, offering an unfiltered look at what it really takes to build a successful health tech venture.
This event follows the launch of our NHS Market Access Accelerator earlier in the day, so it is also a great opportunity to meet this year’s cohort and learn more about their exciting solutions.
With nibbles and networking, we look forward to seeing you at this free event!